Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis
In randomized trial, oral elafibranor induced biochemical response at 1 year in 51% of patients
Source: medpagetoday.com
Stay updated with breaking news from Jay Hoofnagle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In randomized trial, oral elafibranor induced biochemical response at 1 year in 51% of patients
The potential first-in-class antisense RNA-based therapy led to sustained clearance of HBsAg and HBV DNA for 24 weeks after treatment ended in the phase 2b study.
Quotable quotes heard by <em>MedPage Today</em>'s reporters
Lawfare’s daily roundup of national security news and opinion.